Alfa Digital Co., Ltd.
Update：2026/08/06
Industries
Main Industry
Software
Main Product/Service
Future PharmaTech uses its proprietary “Future‑AI platform,” integrating drug repurposing and mechanism simulation to develop novel compounds capable of penetrating the blood‑brain barrier (BBB), targeting conditions such as vascular dementia (VD) and ere
Founded Year
2023
Unified Business No.
94004036
Status
Active
Number of Employees
0
Total Paid-in
Capital
8,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Future PharmaTech, founded in 2021, focuses on neurological and vascular disorders, leveraging its proprietary AI‑driven drug discovery platform and nanomedicine technologies to rapidly develop effective, safe and precision therapies designed to improve p
